Paeds Cases · preventive-and-community-paediatrics
Vaccine safety OSCE — pre-vaccination screen, anaphylaxis drill and false-contraindication counselling
Observed structured encounter testing vaccine safety screening, emergency anaphylaxis response and counselling through false contraindications.
On this page & tools
Target exams
Station objectives
- Perform a structured pre-vaccination safety screen. [1]
- Separate true contraindications from precautions and false barriers. [1] [4]
- Manage vaccine anaphylaxis with adrenaline first. [2]
- Communicate AEFI follow-up and antigen-specific planning. [2] [5]
- Avoid converting myths into permanent under-immunisation. [4] [6]
Candidate brief
You are the paediatric doctor in a community immunisation clinic attached to an acute paediatric service. Station A is 10 minutes. Station B is 8 minutes. Examiners score safety language, prioritisation and partnership. [1] [2]
Station A — Pre-vaccination screen and counselling
Setup: Caregiver of a well 4-month-old with mild rhinitis. Concerns include antibiotics last week, family history of febrile seizures, and “vaccines cause autism.” Vaccines are due today. [1] [4]
Expected actions:
- Confirm identity, record and vaccines due. [1]
- Screen anaphylaxis history, immunocompromise, severe illness, pregnancy/live relevance, recent antibody products. [1] [3]
- Classify mild rhinitis, antibiotics and family seizure/autism concerns as non-contraindications. [1] [4]
- Decide to vaccinate if screen clear; explain expected reactions and safety-net. [1]
- Use non-judgemental evidence language on autism without overloading jargon. [4] [6] [7]
Station B — Anaphylaxis drill
Setup: Minutes after injection the child has generalised urticaria, wheeze and becomes floppy with poor perfusion. [2]
Expected actions:
- Declare anaphylaxis and call for help. [2]
- Give IM adrenaline anterolateral thigh immediately. [2]
- Airway support/oxygen; fluids if shocked; repeat adrenaline if needed. [2]
- Avoid leading with antihistamine or steroid. [2]
- Plan observation/admission, AEFI report, chart flag for culprit vaccine, and specialist follow-up for future antigens. [2] [5]
Marking anchors
Clear pass: correct three-bucket triage, vaccinate through false barriers, adrenaline-first anaphylaxis management, clear AEFI documentation plan. [1] [2] [4]
Borderline: right labels but delays vaccination for mild illness, or adrenaline delayed while fetching antihistamine. [1] [2]
Fail: accepts autism family history as contraindication; calls syncope-only features anaphylaxis without systemic allergy logic; no reporting or future-plan after anaphylaxis. [4] [2] [5]
Debrief pearls
- Mild illness ≠ contraindication. [1]
- Anaphylaxis is rare; unreadiness is the preventable failure. [2]
- Passive AEFI lists are not automatic proof of causation. [5]
- ITP after MMR is rare and usually self-limited; do not abandon all vaccines without a plan. [8]
References
- [1]Kroger AT General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2006.PMID 17136024
- [2]McNeil MM Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol, 2016.PMID 26452420
- [3]Medical Advisory Committee of the Immune Deficiency Foundation Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol, 2014.PMID 24582311
- [4]Hviid A Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. Ann Intern Med, 2019.PMID 30831578
- [5]Varricchio F Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J, 2004.PMID 15071280
- [6]Gerber JS Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis, 2009.PMID 19128068
- [7]Di Pietrantonj C Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev, 2021.PMID 34806766
- [8]France EK Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics, 2008.PMID 18310189